top of page
Independent Medical Leadership for Clinical Development
æquanimitas /eh-kwah-NEE-mee-tas/ n,
coolness and presence of mind under all circumstances
The practice takes its name from Osler's Aequanimitas, his 1889 address on imperturbability: the composure to think clearly when the people around you cannot. Early drug development often produces urgency faster than it produces clarity, and the pressure to act tends to arrive before the understanding does. Independent medical leadership holds that steadiness on a team's behalf.
Fractional CMO leadership and independent clinical development advisory for emerging biopharma companies navigating high-stakes development decisions
æquanimitas helps biopharma leaders translate promising science into clinically credible, patient-centered development programs - through clinical strategy, IND readiness, first-in-human protocol & safety stress testing, program reset support, and independent safety oversight
bottom of page